A detailed history of Susquehanna International Group, LLP transactions in Exact Sciences Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 265,212 shares of EXAS stock, worth $18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
265,212
Previous 293,987 9.79%
Holding current value
$18 Million
Previous $20.3 Million 44.81%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$41.33 - $74.26 $1.19 Million - $2.14 Million
-28,775 Reduced 9.79%
265,212 $11.2 Million
Q1 2024

May 07, 2024

BUY
$56.27 - $73.77 $13.4 Million - $17.6 Million
238,556 Added 430.37%
293,987 $20.3 Million
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $1.58 Million - $2.02 Million
26,723 Added 93.09%
55,431 $4.1 Million
Q3 2023

Nov 14, 2023

BUY
$65.94 - $99.04 $94,426 - $141,825
1,432 Added 5.25%
28,708 $1.96 Million
Q2 2023

Aug 11, 2023

SELL
$62.68 - $95.05 $2.54 Million - $3.85 Million
-40,520 Reduced 59.77%
27,276 $2.56 Million
Q1 2023

May 16, 2023

SELL
$47.19 - $70.77 $4.04 Million - $6.05 Million
-85,541 Reduced 55.79%
67,796 $4.6 Million
Q4 2022

Feb 14, 2023

SELL
$30.35 - $53.15 $5.11 Million - $8.96 Million
-168,523 Reduced 52.36%
153,337 $7.59 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $2.14 Million - $3.3 Million
66,802 Added 26.19%
321,860 $10.5 Million
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $5.72 Million - $12.2 Million
160,501 Added 169.74%
255,058 $10 Million
Q1 2022

May 16, 2022

SELL
$57.56 - $82.54 $14.2 Million - $20.4 Million
-247,239 Reduced 72.34%
94,557 $6.61 Million
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $8.5 Million - $11.8 Million
117,240 Added 52.21%
341,796 $26.6 Million
Q3 2021

Nov 15, 2021

SELL
$90.24 - $124.05 $9.41 Million - $12.9 Million
-104,247 Reduced 31.71%
224,556 $21.4 Million
Q2 2021

Aug 11, 2021

BUY
$93.66 - $139.27 $8.24 Million - $12.2 Million
87,938 Added 36.51%
328,803 $40.9 Million
Q1 2021

May 17, 2021

SELL
$116.57 - $155.01 $2.35 Million - $3.13 Million
-20,179 Reduced 7.73%
240,865 $31.7 Million
Q4 2020

Feb 16, 2021

BUY
$99.61 - $142.12 $7.44 Million - $10.6 Million
74,729 Added 40.11%
261,044 $34.6 Million
Q3 2020

Nov 16, 2020

SELL
$72.92 - $102.01 $16.7 Million - $23.4 Million
-229,668 Reduced 55.21%
186,315 $19 Million
Q2 2020

Aug 14, 2020

SELL
$55.75 - $92.75 $9.07 Million - $15.1 Million
-162,605 Reduced 28.1%
415,983 $36.2 Million
Q1 2020

May 15, 2020

BUY
$37.9 - $104.44 $11.2 Million - $30.8 Million
294,690 Added 103.8%
578,588 $33.6 Million
Q4 2019

Feb 14, 2020

BUY
$77.66 - $99.74 $9.9 Million - $12.7 Million
127,519 Added 81.54%
283,898 $26.3 Million
Q3 2019

Nov 14, 2019

SELL
$90.37 - $122.49 $11.6 Million - $15.8 Million
-128,827 Reduced 45.17%
156,379 $14.1 Million
Q2 2019

Aug 16, 2019

BUY
$89.51 - $118.04 $11 Million - $14.5 Million
122,992 Added 75.82%
285,206 $33.7 Million
Q2 2019

Aug 14, 2019

BUY
$89.51 - $118.04 $6.33 Million - $8.34 Million
70,682 Added 77.22%
162,214 $19.1 Million
Q1 2019

May 15, 2019

SELL
$61.98 - $96.5 $350,868 - $546,286
-5,661 Reduced 5.82%
91,532 $7.93 Million
Q4 2018

Feb 14, 2019

SELL
$56.04 - $82.66 $13.3 Million - $19.7 Million
-237,780 Reduced 70.98%
97,193 $6.13 Million
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $13.3 Million - $22.3 Million
-276,376 Reduced 45.21%
334,973 $26.4 Million
Q2 2018

Aug 14, 2018

BUY
$37.84 - $69.96 $21.5 Million - $39.7 Million
567,154 Added 1283.3%
611,349 $36.6 Million
Q1 2018

May 15, 2018

BUY
$39.82 - $57.53 $460,757 - $665,679
11,571 Added 35.47%
44,195 $1.78 Million
Q4 2017

Feb 14, 2018

BUY
$46.49 - $60.51 $1.26 Million - $1.64 Million
27,028 Added 482.99%
32,624 $1.71 Million
Q3 2017

Nov 14, 2017

BUY
$37.05 - $47.12 $207,331 - $263,683
5,596
5,596 $264,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.